Axalbion is a clinical-stage pharmaceutical company developing TRPM8 agonists for the treatment of chronic cough and dry eyes, two chronic, common and debilitating disorders, with unmet needs and multi-billion-dollar markets.
Its molecules have a rapid onset of action and offer innovative topical treatment opportunities by normalizing abnormal cough and lacrimation reflexes.
Axalbion’s s strategy is to develop its lead compound AX-8 up-to Phase 2b to show clinical proof of concept across a representative patient population. It has already been tested in a Phase 2a trial with patients suffering from refractory chronic cough.
Axalbion benefits from having proof of concept studies (clinical and non-clinical), strong safety and toxicology data, and the support of world’s leading experts and strategic partners.
WE WELCOME PRIVATE INVESTORS AND VC's TO CONTACT US DIRECTLY FOR FURTHER DETAILS.
contact@axalbion.com
Company Details
- Employees
- 7
- Founded
- -
- Address
- C/o Medicines Evaluation Unit, The Langley Building,switzerland
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- axalbion.com
- Keywords
- Chronic cough, Dry eyes, Small molecules.
- HQ
- Manchester
Axalbion Therapeutics Limited Questions
Axalbion Therapeutics Limited's website is axalbion.com
Axalbion Therapeutics Limited's LinkedIn profile is https://ch.linkedin.com/company/axalbion
Axalbion Therapeutics Limited has
7 employees.
View email and phone details for 7
employees at Axalbion Therapeutics Limited.
Axalbion Therapeutics Limited's industry is
Pharmaceutical Manufacturing
Axalbion Therapeutics Limited's top competitors are
Nocion Therapeutics, Inc.,
Celtic Biotech Ltd,
Trevi Therapeutics, Inc.,
Treatt,
Cann Pharma Consultants,
Evolve,
Biosell Uk,
Frugalpac,
Climb Bio,
Kisano.
Axalbion Therapeutics Limited's categories are Pharmaceutical Manufacturing
Axalbion Therapeutics Limited's founding year is 2021
